The Valley Desk

NCT04535609 · Interventional trial

An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients

Overall registry status Completed

Phase 2

Conditions Primary Mitochondrial Myopathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov